Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wearable Artificial Organs is a private U.S. medical device company developing portable and wearable renal replacement technologies intended to reduce the burden of conventional dialysis. Its lead program is the Wearable Artificial Kidney, a miniaturized continuous dialysis device designed to improve mobility, reduce treatment restrictions, and avoid fistula-based access burdens associated with standard in-center care. The company also presents PCRRT, a cordless portable continuous renal replacement therapy system aimed at critically ill patients who need continuous dialysis support. The business is focused on kidney failure and dialysis innovation rather than therapeutics, and its devices are not yet commercially available. Wearable Artificial Organs appears to be in late R&D with additional human studies still required before FDA approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wearable Artificial Organs.